Ann S. LaCasce MD, MMSc

Ann S. LaCasce, MD, MMSc, is Associate Professor of Medicine at Harvard Medical School and a member of the Lymphoma Program at Dana-Farber Cancer Institute.

Dr. LaCasce received her medical degree from Tufts University School of Medicine. She completed a residency in internal medicine at Brigham and Women's Hospital, where she was Chief Medical Resident. She completed a fellowship in hematology/oncology at Dana-Farber/Partners CancerCare.

Dr. LaCasce specializes in the treatment of lymphoma. Her clinical interests include chronic lymphocytic leukemia, non-Hodgkin and Hodgkin lymphoma, CAR T-cell therapy, and stem cell transplantation for lymphoma. Her research focuses on the development of clinical trials using novel agents in non-Hodgkin's and Hodgkin's lymphoma. Dr. LaCasce serves on the Alliance Lymphoma Core Committee, which develops and executes clinical trials on a national level. She is also Chair Elect of the Scientific Advisory Committee for the Lymphoma Research Foundation.

Dr. LaCasce has a longstanding interest in medical education and serves as the Program Director of the Dana-Farber/Massachusetts General Brigham Fellowship Program in Hematology/Oncology. She also has a strong interest in cancer in young adults and co-directs the Center for Adolescent and Young Adult Oncology at Dana-Farber.

Dr. LaCasce serves on the NCCN B-Cell Lymphomas Panel and the NCCN Panel for Cancer in People with HIV/Kaposi Sarcoma.